A novel RP-HPLC stability-indicating method for simultaneous estimation of Niraparib and Abiraterone in synthetic mixtures and combined tablet formulations
Abstract Niraparib and Abiraterone in a combined dosage form offer a fortunate regimen for treating cancers, mainly those resistant to conventional therapies cast in cancer treatment. The present study intends to develop a novel RP-HPLC method for simultaneously estimating Niraparib and Abiraterone...
Saved in:
| Main Authors: | Krishnaphanisri Ponnekanti, Ramreddy Godela, Divya Reddy Solipeta, K. Sujatha, Durga Prasad Beda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Discover Applied Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s42452-025-06930-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concurrent estimation of Pregabalin and Etoricoxib by new stability indicating RP-UPLC approach: application in assay of commercial tablets
by: Krishnaphanisri Ponnekanti, et al.
Published: (2024-11-01) -
Development and Validation of RP-HPLC Method for the Determination of Dexrabeprazole Sodium
by: Semra Yılmazer Keskin, et al.
Published: (2021-12-01) -
Quality by design driven RP-HPLC method optimization for analysis of levothyroxine and liothyronine in bulk and tablet dosage form
by: Ramdas Darade, et al.
Published: (2025-04-01) -
Development and validation of a RP–HPLC method for the quantization studies of metronidazole in tablets and powders dosage forms
by: Elena Gabriela Oltean,, et al.
Published: (2011-12-01) -
Evaluation of possible approaches to the determination by the method rp hplc natural oils in repellent compositions
by: L. A. Nosikova, et al.
Published: (2015-10-01)